Bretylium Tosylate is an inhibitor of AChE. Bretylium tosylate has a biphasic response, initially inducing norepinephrine release followed by sympathetic ganglionic blockade. Bretylium tosylate is a class III antiarrhythmic agent and a competitive inhibitor of acetylcholinesterase
Soluble in water (50 mg/ml), ethanol, methanol, and chloroform. Insoluble in ether, ethyl acetate, and hexane.
Store at room temperature
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Adobe Acrobat Reader is required to reliably view, print and comment on PDF documents
bvseo_sdk, java_sdk, bvseo-3.2.0
CLOUD, getContent, 98ms
bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of
McGinn et alMcGinn et al. (PubMed ID 24687586) found that Bretylium Tosylate inhibited noradrenergic vasoconstriction and increased postexercise cutaneous vascular conductance. -SCBT Publication Review
To place an order using RMB or to ship to mainland China, please visit www.scbio.cn